Human Mammary Epithelial Cell HMEC Transfection Kit

Modes of administration

Reagent exhibits at least 76% transfection efficiency of siRNA delivery. Transfection efficiency was determined by qRT-PCR.

Description

HMEC is a commonly used group of cells that come from regular human breast cells. Researchers frequently use HMEC to study the development and progression of breast cancer and to explore regular mammary gland biology. HMEC cells have been critical in investigating how breast cancer develops and progresses, including the changes in genetics and epigenetics, environmental and lifestyle factors, and the interaction between cancer cells and surrounding tissue. Scientists also use HMEC cells often to determine how effective new anti-cancer drugs are and identify potential targets and biomarkers of breast cancer. Using HMEC cells is unique because they come from normal breast tissue, allowing researchers to study the initial stages of breast cancer and pinpoint targets for early prevention and intervention. Researchers can also transform HMEC cells to create models of breast cancer in the laboratory, which helps them study the progress of the disease and the effectiveness of new treatments. CD BioSciences provides specialized transfection reagent kits that are optimized for the HMEC breast cancer cell line. These kits ensure that the transfection process is efficient and that the results of experiments are consistent.